RS Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

RS Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$44.3M	Sell	313,728 -42,633	-12%	-$6.28M	0.46%	64
2016 Q1	$46.5M	Sell	356,361 -2,764	-0.8%	-$344K	0.46%	72
2015 Q4	$50.5M	Buy	359,125 +41,992	+13%	+$5.82M	0.45%	81
2015 Q3	$42.1M	Buy	317,133 +104,940	+49%	+$18.1M	0.38%	99
2015 Q2	$37.4M	Sell	212,193 -38,281	-15%	-$6.88M	0.32%	119
2015 Q1	$43.3M	Sell	250,474 -37,354	-13%	-$6.41M	0.39%	95
2014 Q4	$47.1M	Sell	287,828 -2,154	-0.7%	-$358K	0.42%	87
2014 Q3	$46.6M	Sell	289,982 -33,115	-10%	-$5.09M	0.43%	89
2014 Q2	$47.5M	Buy	323,097 +78,045	+32%	+$10.8M	0.4%	98
2014 Q1	$34M	Sell	245,052 -158,331	-39%	-$23.8M	0.2%	149
2013 Q4	$51.1M	Sell	403,383 -327,200	-45%	-$33.9M	0.31%	98
2013 Q3	$67.2M	Buy	730,583 +64,980	+10%	+$5.24M	0.44%	59
2013 Q2	$45.7M	Buy	+665,603	New	+$40.7M	0.33%	90

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RS Investment Management's JAZZ Position: Q2 2016 in Review

RS Investment Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 12% in Q2 2016, selling an estimated $6.28M and leaving 313,728 shares worth $44.3M. The position accounts for 0.46% of the portfolio, ranked #64.

RS Investment Management first reported a position in JAZZ in Q2 2013 and has held it in 13 quarters since. The position peaked at $67.2M in Q3 2013. 367 funds tracked by Wall St. Rank hold JAZZ as of Q2 2016.

RS Investment Management held 313,728 shares of Jazz Pharmaceuticals worth $44.3M as of Q2 2016.
RS Investment Management sold 42,633 Jazz Pharmaceuticals shares in Q2 2016, an estimated $6.28M.
Jazz Pharmaceuticals made up 0.46% of RS Investment Management's portfolio in Q2 2016, its #64 holding.
RS Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 13 quarters since.
RS Investment Management's Jazz Pharmaceuticals position peaked at $67.2M in Q3 2013.
367 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.